Boeing Valuation
Is BA * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BA * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BA * (MX$3065.08) is trading below our estimate of fair value (MX$4071.76)
Significantly Below Fair Value: BA * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BA *?
Other financial metrics that can be useful for relative valuation.
What is BA *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$113.43b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2x |
Enterprise Value/EBITDA | 57.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does BA *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.3x | ||
AIR Airbus | 1.9x | 10.4% | €127.5b |
LMT Lockheed Martin | 1.6x | 2.6% | US$112.1b |
SAF Safran | 3.7x | 10.2% | €87.9b |
RTX RTX | 2x | 6.4% | US$139.4b |
BA * Boeing | 1.5x | 11.2% | Mex$113.4b |
Price-To-Sales vs Peers: BA * is good value based on its Price-To-Sales Ratio (1.5x) compared to the peer average (2.3x).
Price to Earnings Ratio vs Industry
How does BA *'s PE Ratio compare vs other companies in the Global Aerospace & Defense Industry?
Price-To-Sales vs Industry: BA * is good value based on its Price-To-Sales Ratio (1.5x) compared to the Global Aerospace & Defense industry average (2.7x).
Price to Sales Ratio vs Fair Ratio
What is BA *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.5x |
Fair PS Ratio | 1x |
Price-To-Sales vs Fair Ratio: BA * is expensive based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$3,065.08 | Mex$3,734.92 +21.9% | 14.0% | Mex$4,980.84 | Mex$2,905.49 | n/a | 27 |
May ’25 | Mex$2,900.00 | Mex$3,849.21 +32.7% | 15.9% | Mex$5,105.34 | Mex$2,382.49 | n/a | 28 |
Apr ’25 | Mex$3,160.00 | Mex$4,053.52 +28.3% | 10.5% | Mex$4,989.45 | Mex$3,326.30 | n/a | 28 |
Mar ’25 | Mex$3,413.00 | Mex$4,422.03 +29.6% | 9.7% | Mex$5,135.40 | Mex$3,423.60 | n/a | 28 |
Feb ’25 | Mex$3,582.00 | Mex$4,410.04 +23.1% | 10.7% | Mex$5,382.25 | Mex$3,246.44 | n/a | 29 |
Jan ’25 | Mex$4,405.00 | Mex$4,550.60 +3.3% | 12.2% | Mex$5,436.35 | Mex$3,227.83 | n/a | 29 |
Dec ’24 | Mex$4,020.00 | Mex$4,265.45 +6.1% | 9.6% | Mex$5,159.10 | Mex$3,267.43 | n/a | 29 |
Nov ’24 | Mex$3,386.37 | Mex$4,280.89 +26.4% | 9.9% | Mex$4,898.38 | Mex$3,384.34 | n/a | 27 |
Oct ’24 | Mex$3,366.00 | Mex$4,494.61 +33.5% | 10.8% | Mex$5,481.89 | Mex$3,607.43 | n/a | 23 |
Sep ’24 | Mex$3,750.00 | Mex$4,301.18 +14.7% | 10.1% | Mex$5,199.32 | Mex$3,522.12 | n/a | 22 |
Aug ’24 | Mex$4,010.00 | Mex$4,277.07 +6.7% | 10.6% | Mex$5,227.00 | Mex$3,540.87 | n/a | 21 |
Jul ’24 | Mex$3,617.82 | Mex$4,029.86 +11.4% | 9.8% | Mex$5,026.70 | Mex$3,109.30 | n/a | 24 |
Jun ’24 | Mex$3,666.00 | Mex$4,164.81 +13.6% | 9.3% | Mex$5,147.32 | Mex$3,183.91 | n/a | 22 |
May ’24 | Mex$3,698.96 | Mex$4,203.85 +13.6% | 11.5% | Mex$5,251.27 | Mex$2,943.24 | Mex$2,900.00 | 21 |
Apr ’24 | Mex$3,822.75 | Mex$4,113.70 +7.6% | 10.2% | Mex$4,703.85 | Mex$2,939.45 | Mex$3,160.00 | 20 |
Mar ’24 | Mex$3,696.80 | Mex$4,315.09 +16.7% | 10.2% | Mex$4,942.64 | Mex$3,088.67 | Mex$3,413.00 | 21 |
Feb ’24 | Mex$3,998.00 | Mex$4,230.67 +5.8% | 12.3% | Mex$4,898.76 | Mex$3,003.07 | Mex$3,582.00 | 20 |
Jan ’24 | Mex$3,630.01 | Mex$4,005.67 +10.3% | 14.3% | Mex$4,911.20 | Mex$2,377.02 | Mex$4,405.00 | 20 |
Dec ’23 | Mex$3,369.06 | Mex$3,737.82 +10.9% | 15.7% | Mex$4,860.50 | Mex$2,352.48 | Mex$4,020.00 | 20 |
Nov ’23 | Mex$2,835.00 | Mex$3,749.73 +32.3% | 17.3% | Mex$4,953.60 | Mex$1,941.81 | Mex$3,386.37 | 21 |
Oct ’23 | Mex$2,494.40 | Mex$4,339.36 +74.0% | 16.7% | Mex$6,011.61 | Mex$3,227.71 | Mex$3,366.00 | 19 |
Sep ’23 | Mex$3,100.00 | Mex$4,326.82 +39.6% | 16.5% | Mex$6,015.43 | Mex$3,229.76 | Mex$3,750.00 | 19 |
Aug ’23 | Mex$3,430.00 | Mex$4,345.25 +26.7% | 16.6% | Mex$6,051.46 | Mex$3,249.10 | Mex$4,010.00 | 19 |
Jul ’23 | Mex$2,825.00 | Mex$4,313.87 +52.7% | 17.6% | Mex$5,915.51 | Mex$2,977.61 | Mex$3,617.82 | 19 |
Jun ’23 | Mex$2,566.87 | Mex$4,294.34 +67.3% | 17.7% | Mex$5,865.12 | Mex$2,952.24 | Mex$3,666.00 | 21 |
May ’23 | Mex$3,080.00 | Mex$4,684.28 +52.1% | 13.3% | Mex$6,081.79 | Mex$3,673.57 | Mex$3,698.96 | 21 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.